BIOMAT Database Logo BIOMAT Database Logo

Toxicity of papain-digested tetanus toxin. Pathological effect of fragment B in the absence of spastic paralysis. 1978

T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D009128 Muscle Spasticity A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54) Clasp-Knife Spasticity,Spastic,Clasp Knife Spasticity,Spasticity, Clasp-Knife,Spasticity, Muscle
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D010206 Papain A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2. Tromasin
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D005557 Formaldehyde A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) Formalin,Formol,Methanal,Oxomethane
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Toxin-neutralizing effect of antibody against subtilisin-digested tetanus toxin.
June 1979, Infection and immunity,
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Isolation and purification by high performance liquid chromatography of a tetanus toxin fragment (fragment [A-B]) derived from mildly papain-treated toxin.
January 1989, Toxicon : official journal of the International Society on Toxinology,
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Neuropharmacological characterization of fragment B from tetanus toxin.
January 1985, The Journal of pharmacology and experimental therapeutics,
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Tetanus toxin H(C) fragment reduces neuronal MPP+ toxicity.
July 2009, Molecular and cellular neurosciences,
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP+ Toxicity In Vivo.
July 2018, Neurotoxicity research,
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Relation of spastic and flaccid paralysis to retrograde transport of 125I-tetanus toxin and its 125I-Ibc fragment. Modulating effect of F (ab) antibodies directed to specific areas on the toxin molecule.
January 1985, Bollettino dell'Istituto sieroterapico milanese,
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
[Pathological anatomy of cerebral spastic paralysis].
September 1966, Wiener medizinische Wochenschrift (1946),
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Expression of tetanus toxin fragment C.
January 1998, Methods in molecular biology (Clifton, N.J.),
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
March 1984, The Journal of pharmacology and experimental therapeutics,
T B Helting, and H J Ronneberger, and R Vollerthun, and V Neubauer
Isolation and properties of an enzymatically active fragment from papain-digested myosin.
May 1968, Biochimica et biophysica acta,
Copied contents to your clipboard!